Article
Triggering Receptor Expressed on Myeloid Cell 2 R47H Exacerbates Immune Response in Alzheimer's Disease Brain.
Frontiers in immunology - 1 Jan 2020
Korvatska Olena, Kiianitsa Kostantin, Ratushny Alexander, Matsushita Mark, Beeman Neal, Chien Wei-Ming, Satoh Jun-Ichi, Dorschner Michael O, Keene C Dirk, Bammler Theo K, Bird Thomas D, Raskind Wendy H
Abstract excerpt
The R47H variant in the microglial triggering receptor expressed on myeloid cell 2 (TREM2) receptor is a strong risk factor for Alzheimer's disease (AD). To characterize processes affected by R47H, we performed an integrative network analysis of genes expressed in brains of AD patients with R47H, sporadic AD without the variant, and patients with polycystic lipomembranous osteodysplasia with sclerosing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
